MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin
Xin Zhang(Chinese National Human Genome Center), Chuanxin Wang(Qilu Hospital of Shandong University)
Cited by 57
Related Papers
MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2
|Molecular Cancer Therapeutics|2017|249
Phospholipid Phosphatase 4 promotes proliferation and tumorigenesis, and activates Ca2+-permeable Cationic Channel in lung carcinoma cells
|Molecular Cancer|2017|67
Characterization of a dual <scp>BET</scp>/<scp>HDAC</scp> inhibitor for treatment of pancreatic ductal adenocarcinoma
|International Journal of Cancer|2020|52
Aberrant expression of circulating Th17, Th1 and Tc1 cells in patients with active and inactive ulcerative colitis
|International Journal of Molecular Medicine|2013|43